|
|
 |
|
Viewing report
|
|
 |
 |
Antibacterial Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
ADIS, Jan 2001, Pages: 140
This report is designed to provide a useful tool to professionals in research and development (R&D), marketing, business development, licensing, and strategic planning who are involved, or are anticipating involvement, in the discovery, development, licensing, and/or marketing of therapeutics and prophylactics for the treatment of bacterial infections.
Customers who bought this item also bought
Antibacterial: Drug Licensing Opportunities, 2002
Antibacterial Market Survey: Analyses and Forecasts�Technology, Sales and Company Profiles
Stakeholder Opinions: Nosocomial Infections - The Need for New Gram-negative Drugs
Antibiotics - Global Strategic Business Report
The Global Market for AntiMicrobials and Antifungals; Challenging Resistance to 2015
Antibiotic Resistance: Opinion Leader Forum, 2002
Stakeholder Opinions: Urinary Tract Infections - Ciprofloxacin Leads the Way
The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape
Antibiotics and Drug Resistance
Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success
Overcoming Challenges in Antibacterial Drug Discovery and Development
Animal Health Products Antibacterials Markets
|
 |
|
|